Terns Pharmaceuticals logo

Terns Pharmaceuticals Share Price Today

(NASDAQ: TERN)

Terns Pharmaceuticals share price is $3.63 & ₹316.05 as on 6 Mar 2025, 2.30 'hrs' IST

$3.63

0.12

(3.42%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Terns Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Terns Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Terns Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Terns Pharmaceuticals share price movements

  • Today's Low: $3.50
    Today's High: $3.68

    Day's Volatility :4.89%

  • 52 Weeks Low: $3.27
    52 Weeks High: $11.40

    52 Weeks Volatility :71.31%

Terns Pharmaceuticals (TERN) Returns

PeriodTerns Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-43.63%
3.7%
0.0%
6 Months
-51.34%
-2.8%
0.0%
1 Year
-55.68%
2.5%
0.0%
3 Years
15.61%
12.9%
-11.6%

Terns Pharmaceuticals (TERN) Key Statistics

in dollars & INR

Previous Close
$3.51
Open
$3.51
Today's High
$3.68
Today's Low
$3.5
Market Capitalization
$298.1M
Today's Volume
$988.0K
52 Week High
$11.4
52 Week Low
$3.2711
Revenue TTM
$1000.0K
EBITDA
$-99.7M
Earnings Per Share (EPS)
$-1.22
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-28.28%

How to invest in Terns Pharmaceuticals Stock (TERN) from India?

It is very easy for Indian residents to invest directly in Terns Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Terns Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Terns Pharmaceuticals or TERN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Terns Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Terns Pharmaceuticals shares which would translate to 0.240 fractional shares of Terns Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Terns Pharmaceuticals, in just a few clicks!

Returns in Terns Pharmaceuticals (TERN) for Indian investors in Rupees

The Terns Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Terns Pharmaceuticals investment value today

Current value as on today

₹49,387

Returns

₹50,613

(-50.61%)

Returns from Terns Pharmaceuticals Stock

₹55,678 (-55.68%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Terns Pharmaceuticals (TERN)

143%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Terns Pharmaceuticals Stock from India on INDmoney has increased by 143% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Terns Pharmaceuticals

  • Soleus Capital Management, L.P.

    9.59%

  • Orbimed Advisors, LLC

    8.90%

  • Vivo Capital, LLC

    8.12%

  • BlackRock Inc

    6.76%

  • Deep Track Capital, LP

    6.57%

  • Schonfeld Strategic Advisors LLC

    5.59%

Analyst Recommendation on Terns Pharmaceuticals

Buy

    78%Buy

    21%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Terns Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Terns Pharmaceuticals Stock (TERN)

What analysts predicted

Upside of 425.14%

Target:

$19.06

Current:

$3.63

Insights on Terns Pharmaceuticals Stock (Ticker Symbol: TERN)

  • Price Movement

    In the last 3 months, TERN stock has moved down by -44.6%
  • TERN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 122.2%
  • TERN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 41.6%
  • Price to Sales

    ForTERN every $1 of sales, investors are willing to pay $103.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Terns Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Terns Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Terns Pharmaceuticals (TERN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Terns Pharmaceuticals Inc logo
-19.69%
-51.34%
-55.68%
15.61%
-80.26%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Terns Pharmaceuticals Inc logo
NA
NA
NA
-1.2
-0.28
-0.19
NA
4.29
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Terns Pharmaceuticals Inc logo
Buy
$298.1M
-80.26%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Terns Pharmaceuticals

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Organization
Terns Pharmaceuticals
Employees
66
CEO
Ms. Amy L. Burroughs M.B.A.
Industry
Services

Management People of Terns Pharmaceuticals

NameTitle
Ms. Amy L. Burroughs M.B.A.
CEO & Director
Mr. Andrew W. Gengos
Chief Financial Officer
Ms. Elona Kogan Esq., J.D.
Chief Legal Officer
Dr. Jeffrey R. Jasper Ph.D.
Senior Vice President of Research
Dr. Emil T. Kuriakose M.D.
Chief Medical Officer
Ms. Melita Sun Jung
Chief Business Officer
Mr. Scott Harris
Chief Development Officer
Ms. Debra Sieminski
Senior Vice President of Medical Affairs
Mr. James Kanter
Senior VP of CMC
Mr. David Eric Strauss
VP of Finance & Controller

Important FAQs about investing in TERN Stock from India :

What is Terns Pharmaceuticals share price today?

Terns Pharmaceuticals share price today stands at $3.63, Open: $3.51 ; Previous Close: $3.51 ; High: $3.68 ; Low: $3.50 ; 52 Week High: $11.40 ; 52 Week Low: $3.27.

The stock opens at $3.51, after a previous close of $3.51. The stock reached a daily high of $3.68 and a low of $3.50, with a 52-week high of $11.40 and a 52-week low of $3.27.

Can Indians buy Terns Pharmaceuticals shares?

Yes, Indians can invest in the Terns Pharmaceuticals (TERN) from India.

With INDmoney, you can buy Terns Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Terns Pharmaceuticals at zero transaction cost.

How can I buy Terns Pharmaceuticals shares from India?

It is very easy to buy Terns Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Terns Pharmaceuticals (TERN) be purchased?

Yes, you can buy fractional shares of Terns Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Terns Pharmaceuticals stocks?

To start investing in Terns Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Terns Pharmaceuticals Stock (TERN)?

Today’s highest price of Terns Pharmaceuticals (TERN) is $3.68.

Today’s lowest price of Terns Pharmaceuticals (TERN) is $3.50.

What is today's market capitalisation of Terns Pharmaceuticals?

Today's market capitalisation of Terns Pharmaceuticals TERN is 298.1M

What is the 52 Week High and Low Range of Terns Pharmaceuticals Stock (TERN)?

  • 52 Week High

    $11.40

  • 52 Week Low

    $3.27

What are the historical returns of Terns Pharmaceuticals (TERN)?

  • 1 Month Returns

    -19.69%

  • 3 Months Returns

    -51.34%

  • 1 Year Returns

    -55.68%

  • 5 Years Returns

    -80.26%

Who is the Chief Executive Officer (CEO) of Terns Pharmaceuticals ?

Ms. Amy L. Burroughs M.B.A. is the current Chief Executive Officer (CEO) of Terns Pharmaceuticals.